Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sandoz
Sandoz
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
Novartis off to scorching start with Copaxone generic Glatopa
Fierce Pharma Marketing
Mon, 07/13/15 - 11:11 am
Novartis
Copaxone
generics
Glatopa
MS
multiple scleroiss
Momenta
Sandoz
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Teva Pharmaceutical
Momenta
Sandoz
generics
Novartis
Copaxone
MS
multiple sclerosis
U.S. court nixes Teva's Copaxone patent--again
Fierce Pharma
Thu, 06/18/15 - 04:00 pm
Copaxone
patents
Teva Pharmaceuticals
generics
Momenta
Novartis
Sandoz
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Novartis
Neupogen
biosimilars
Zarxio
Amgen
Sandoz
Amgen motion to delay Neupogen biosimilar denied
Medical Marketing and Media
Fri, 04/17/15 - 08:44 am
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Denied Again! Another Obstacle to Biosimilar First Launch Falls with FDA Rejection of Amgen’s Certification Petition
FDA Law Blog
Fri, 03/27/15 - 08:39 am
Amgen
biosimilars
FDA
Sandoz
Neupogen
Zarxio
U.S. judge rejects Amgen injunction bid against Novartis Sandoz unit
Yahoo/Reuters
Fri, 03/20/15 - 11:00 am
Amgen
Neupogen
Novartis
Sandoz
biosimilars
Novartis Pays $12.6M Fine for Giving Inaccurate Pricing Data to Medicare
WSJ Pharmalot
Mon, 03/16/15 - 03:00 pm
Novartis
Sandoz
Medicare
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Novartis
FDA
Neupogen
Zarxio
Sandoz
Amgen
Sandoz gets ready to make the biosimilar case with oncologists
Medical Marketing and Media
Thu, 01/22/15 - 09:51 am
Sandoz
biosimilars
physicians
oncologists
Neupogen
Zarxio
Novartis
Drug companies find common ground over Colorado's 'biosimilars' legislation
Bizjournals.com
Wed, 01/21/15 - 09:42 am
Colorado
biologics
generics
Amgen
Sandoz
FDA panel recommends approval for first generic biotech drug
Marketwatch
Wed, 01/7/15 - 06:49 pm
FDA
advisory panels
biosimilars
Neupogen
Amgen
Novartis
Sandoz
Novartis copy of Amgen biotech drug shows similar efficacy-study
Yahoo/Reuters
Mon, 12/8/14 - 08:24 am
Novartis
Amgen
Neupogen
biosimilars
Sandoz
neutropenia
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Sandoz
psoriasis
Amgen
Enbrel
generics
Amgen and Sandoz Square Off Over a Biosimilar Application
WSJ Pharmalot
Mon, 11/3/14 - 11:45 am
Amgen
Sandoz
biosimilars
Neupogen
Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft
FDA Law Blog
Thu, 10/30/14 - 05:43 pm
Amgen
Sandoz
Neupogen
biosimilars
Biosimilar preclinical demand growing as US market beckons, says Harlan
Biopharma-Reporter
Fri, 08/8/14 - 09:34 am
biosimilars
Sandoz
Novartis
FDA
Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Motley Fool
Mon, 07/21/14 - 10:43 am
Allergan
layoffs
Anacor
Sinovac Biotech
Kerydin
earnings
China
Sandoz
vaccines
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thu, 06/19/14 - 05:47 pm
NUVIGIL
patents
Teva Pharmaceuticals
Sandoz
Apotex
Mylan Labs
Actavis
Lupin
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »